Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Marrone Bio Innovations Files Registration Statement For Proposed Initial Public Offering

July 1, 2013

DAVIS, Calif., July 1, 2013 /PRNewswire/ — Marrone Bio Innovations, Inc. (MBI), a provider of bio-based pest management and plant health products for the agricultural and water treatment markets, announced today that it has filed a registration statement of the form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be sold and the price range for the proposed offering have not yet been determined.

Jefferies LLC and Piper Jaffray & Co. will act as lead joint book-running managers for the offering, and Stifel, Nicolaus & Company and Roth Capital Partners will act as co-managers for the offering.

A copy of the prospectus related to the offering, when available, can be obtained from Jefferies LLC, Equity Syndicate Prospectus Department, at 520 Madison Avenue, New York, New York, 10022, or by calling (877) 547-6340, or by emailing Prospectus_Department@Jefferies.com, and from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by calling (800) 747-3924 or by emailing prospectus@pjc.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

SOURCE Marrone Bio Innovations, Inc.


Source: PR Newswire